Executive Function Screening in Functional Dissociative Seizures

Recently, a landmark study by Zafari R et al. explored functional dissociative seizures executive function using the Frontal Assessment Battery (FAB). Functional/dissociative seizures (FDS) are clinical episodes that closely mimic epileptic seizures. However, these events arise from a complex biopsychosocial basis rather than abnormal electrical brain activity. Consequently, diagnosing and managing these patients remains a significant challenge for neurologists and psychiatrists. Emerging evidence suggests that cognitive impairments, particularly in the executive domain, are prevalent among individuals with FDS. Therefore, clinicians require rapid and reliable screening tools to identify these deficits during routine evaluations. The study demonstrates that the Frontal Assessment Battery serves as an effective instrument for this purpose. By comparing fifty patients with FDS against fifty healthy controls, researchers identified clear cognitive disparities. Moreover, the results highlight the potential for standardized screening to improve diagnostic pathways and therapeutic interventions.

Understanding Functional Dissociative Seizures and Executive Health

Functional dissociative seizures represent a common presentation in specialized epilepsy clinics worldwide. Specifically, these episodes are classified as a subtype of functional neurological disorder. Patients often experience significant distress and disability due to the unpredictable nature of their symptoms. Furthermore, the underlying etiology involves a complicated interplay of psychological trauma, personality traits, and neurobiological vulnerabilities. While FDS is not a primary seizure disorder, it often involves profound cognitive shifts. Notably, many patients report subjective difficulties with concentration, memory, and decision-making. Researchers have recently focused on the executive health of these individuals to better understand their cognitive profile. Executive functions include higher-order processes such as planning, inhibition, and mental flexibility. Consequently, impairments in these areas can severely impact a patient's quality of life and social functioning. By examining functional dissociative seizures executive performance, medical professionals can gain deeper insights into the patient's daily struggles. This understanding allows for a more empathetic and targeted approach to clinical care. Indeed, recognizing executive dysfunction is the first step toward implementing comprehensive cognitive rehabilitation strategies. Therefore, the integration of neuropsychological screening into standard FDS management is increasingly viewed as essential for holistic patient care.

The Utility of the Frontal Assessment Battery in Screening

The Frontal Assessment Battery is a well-established tool used to assess frontal lobe functions at the bedside. It consists of six specific subtests that target different aspects of executive control. These subtests include conceptualization, mental flexibility, motor programming, sensitivity to interference, inhibitory control, and environmental autonomy. Furthermore, the battery is quick to administer, usually taking less than ten minutes. This efficiency makes it an ideal screening tool for busy clinicians in India and across the globe. Specifically, the 'similarities' task evaluates conceptual thinking, while 'lexical fluency' measures mental flexibility. Additionally, the 'motor series' task probes the ability to execute sequential movements. The 'conflicting instructions' and 'Go-No-Go' tasks evaluate the patient's inhibitory control and sensitivity to interference. Finally, the 'prehension behavior' task checks for environmental autonomy. Each of these domains is critical for independent living and professional success. Importantly, the study by Zafari et al. used this comprehensive approach to characterize the screening profiles of FDS patients. They found that individuals with FDS performed significantly worse across these measures compared to their healthy counterparts. Consequently, the FAB provides an objective metric to quantify cognitive challenges that might otherwise remain hidden during a traditional neurological examination. By using such a structured tool, practitioners can standardize their evaluations and ensure no critical cognitive deficit is overlooked.

Analyzing Cognitive Disparities: FDS vs. Healthy Controls

The comparative analysis between fifty patients with FDS and fifty healthy controls yielded striking results. Specifically, the mean FAB score for individuals with FDS was significantly lower than the score for the control group. This difference was statistically significant with a p-value of less than 0.001. Furthermore, the lower scores across various subtests suggest a widespread impairment in executive processing. Consequently, these findings reinforce the idea that FDS is not merely a psychological condition but involves measurable cognitive alterations. Moreover, the study utilized receiver operating characteristic (ROC) curve analysis to evaluate the tool's discriminative performance. The analysis produced an area under the curve (AUC) of 0.89, which indicates high diagnostic accuracy. Therefore, the FAB effectively distinguishes between healthy executive function and the impairments associated with dissociative seizures. Notably, these results align with previous studies that have identified frontal lobe dysfunction in other functional neurological disorders. However, the specificity of these findings for FDS highlights the unique cognitive burden faced by this patient population. Resultantly, clinicians should be aware that these patients might struggle with tasks requiring complex organization or behavioral inhibition. Understanding these disparities is crucial for setting realistic expectations for recovery. It also helps in explaining the nature of the condition to the patients and their families. When patients understand that their cognitive symptoms have an objective basis, it can reduce the stigma often associated with FDS.

Sensitivity and Specificity of the FAB in Diagnosis

One of the most clinically relevant findings of the study is the identification of an optimal cutoff score. Specifically, the researchers determined that a cutoff score of 15.5 on the Frontal Assessment Battery maximizes diagnostic utility. At this threshold, the tool demonstrated a sensitivity of 78% and a specificity of 90%. Therefore, a score below 15.5 should alert the clinician to potential executive dysfunction. Furthermore, the high specificity means that a low score is highly likely to represent a true deficit rather than a false positive. Consequently, this benchmark provides a clear guideline for practitioners when interpreting screening results. In a clinical setting, this high degree of accuracy allows for more confident referrals to neuropsychologists for comprehensive testing. Moreover, identifying these deficits early can prevent the escalation of functional disability. Resultantly, the FAB acts as a vital gatekeeper in the diagnostic process. Importantly, clinicians should use this cutoff in conjunction with other clinical findings and patient history. While the FAB is a powerful screening tool, it does not replace a full neurological workup. However, it significantly strengthens the clinical assessment by providing quantifiable data. This objective evidence is particularly valuable in multi-disciplinary teams where neurologists and psychiatrists must collaborate closely. Eventually, the widespread adoption of standardized cutoffs can lead to more consistent diagnostic practices across different hospitals and clinics.

Holistic Management Strategies for Cognitive Deficits

The identification of executive dysfunction in FDS patients necessitates a multi-disciplinary management approach. Specifically, treatment should not only target the frequency of seizures but also address the underlying cognitive impairments. Furthermore, cognitive behavioral therapy (CBT) remains the gold standard for treating the psychological components of FDS. However, incorporating cognitive rehabilitation can further improve patient outcomes. Therefore, therapists should focus on strategies to improve inhibition, attention, and mental flexibility. Additionally, involving family members in the education process is vital for creating a supportive environment. Resultantly, patients may experience improved social integration and vocational stability. Moreover, clinicians in India should adapt these screening practices to local languages and cultural contexts to ensure accuracy. Specifically, the lexical fluency task may require adjustments based on the patient's primary language. Despite these considerations, the core principles of executive screening remain universally applicable. In conclusion, the study by Zafari et al. provides a robust framework for improving the care of individuals with functional seizures. By utilizing the Frontal Assessment Battery, doctors can objectively measure and monitor cognitive health. This proactive approach ensures that patients receive the comprehensive support they need to manage both their seizures and their cognitive challenges effectively. Eventually, this holistic perspective will lead to better long-term recovery and enhanced quality of life for those living with FDS.

How does the Frontal Assessment Battery (FAB) distinguish FDS from healthy individuals?

The Frontal Assessment Battery assesses cognitive flexibility, motor programming, and inhibitory control. Therefore, it effectively highlights deficits often seen in FDS patients compared to healthy individuals. The study by Zafari et al. shows that patients with FDS consistently score lower across these executive domains. Consequently, clinicians can use these scores to identify patients who may need further neuropsychological evaluation. This distinction is vital for ensuring patients receive appropriate psychiatric and neurological support early.

What are the key components of the FAB used in neurological screening?

The FAB comprises six specific subtests focusing on different frontal lobe functions. These include conceptualization, mental flexibility, motor programming, sensitivity to interference, inhibitory control, and environmental autonomy. Furthermore, these tests provide a rapid assessment of the patient's executive health. Because these domains are frequently impaired in FDS, the battery serves as a robust screening tool. Consequently, medical professionals can objectively measure cognitive shifts that might otherwise remain unnoticed during a standard clinical interview.

Why is the specific cutoff score of 15.5 significant for clinical practice?

A cutoff score of 15.5 provides a balanced approach to diagnostic accuracy. Specifically, it offers a sensitivity of 78% and a specificity of 90%. Therefore, this threshold helps doctors distinguish between healthy executive function and the impairments associated with FDS. If a patient scores below this level, the likelihood of functional seizure-related cognitive dysfunction increases significantly. Consequently, using this specific numerical benchmark allows for more standardized diagnostic protocols across various neurological and psychiatric clinics.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional diagnosis. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Zafari R et al. Executive function in functional/dissociative seizures: screening using the frontal assessment battery. Epilepsy Behav. 2026 Jul 05. doi: undefined. PMID: 42402246.

Reuber M, et al. Functional neurological disorder: seizures. J Neurol Neurosurg Psychiatry. 2021.

Dubois B, et al. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000.